Intellectual Property - August 7, 2026
SynAct Pharma receives favorable US patent decision
The Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) has issued a favorable Decision on Appeal in U.S. patent application No. 18/065,702, Appeal No. 2026-000924, relating to an immediate-release solid oral dosage formulation of resomelagon (AP1189 acetate).
Intellectual Property - July 30, 2026
Medivir receives US patent notice for fostrox-lenvatinib combination
Medivir has received a Notice of Allowance from the US Patent and Trademark Office for its patent application covering the combination of fostroxacitabine bralpamide (fostrox) and lenvatinib in hepatocellular carcinoma and liver metastases.
Legal Advice article - July 7, 2026
VibroSense Dynamics initiates legal negotiations with its Chinese distributor
VibroSense Dynamics has initiated legal proceedings to address a breach of the exclusive agreement signed with VibroSense's Chinese distributor Genertec Universal Medical Group Co, a subsidiary of General Technology Holding Co.
Intellectual Property - May 29, 2026
Getinge’s subsidiary Maquet Cardiovascular receives adverse jury trial verdict in patent infringement dispute
A jury in the United States District Court for the District of Massachusetts has delivered a verdict in favor of Abiomed in a patent dispute between Maquet Cardiovascular and Abiomed.
Intellectual Property - May 19, 2026
Mucocort receives US patent approval
The company has received a patent in the United States for its mucoadhesive patch technology, M045A, developed for the treatment of recurrent aphthous stomatitis (mouth ulcers).
Intellectual Property - May 4, 2026
Gradientech receives US patent allowance
Gradientech has received a Notice of Allowance in the United States for its single-use microfluidic test, a key component of the CE marked QuickMIC system.
